| Trial ID: | L0102 |
| Source ID: | NCT01147523
|
| Associated Drug: |
Spironolactone
|
| Title: |
Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease
|
| Acronym: |
NAFLD
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver|Steatohepatitis
|
| Interventions: |
Drug: Spironolactone/Vitamin E
|
| Outcome Measures: |
Serum adipocytokines levels|Serum homocysteine levels|Liver histology|Insulin resistance|Hormonal profile|Serum biochemistry|Reactive Oxygen Metabolites (ROMs)
|
| Sponsor/Collaborators: |
Aristotle University Of Thessaloniki
|
| Gender: |
All
|
| Age: |
18 Years to 75 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
30
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
January 2010
|
| Completion Date: |
December 2011
|
| Results First Posted: |
--
|
| Last Update Posted: |
January 20, 2012
|
| Locations: |
Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece
|
| URL: |
https://ClinicalTrials.gov/show/NCT01147523
|
